Results for cellehyperplasi translation from Danish to English

intestinal metaplasi blev også observeret, ligesom leydig cellehyperplasi og benigne leydig celletumorer.
intestinal metaplasia was also observed, as were leydig cell hyperplasia and bening leydig cell tumours.

karcinogenicitetsstudier med rotter med den racemiske blanding har vist gastrisk ecl-cellehyperplasi og carcinoider.
carcinogenicity studies in the rat with the racemic mixture have shown gastric ecl-cell hyperplasia and carcinoids.

i et karcinogenstudie udviklede hanrotter leydig- cellehyperplasi og adenomer pga. pramipexols prolaktinhæmmende effekt.
in a carcinogenicity study, male rats developed leydig cell hyperplasia and adenomas, explained by the prolactin-inhibiting effect of pramipexole.

i carcinogenicitetsundersøgelser hos mus udvikledes dosis- relateret gastrisk ecl cellehyperplasi såvel som levertumorer og adenom af rete testis.
in mouse carcinogenicity studies dose-related gastric ecl cell hyperplasia developed as well as liver tumours and adenoma of rete testis.

i to carcinogenicitetsundersøgelser på rotter frembragte lansoprazol dosis- relateret gastrisk ecl cellehyperplasi og ecl cellecarcinoider forbundet med hypergastrinæmi grundet hæmning af syresekretion.
in two rat carcinogenicity studies, lansoprazole produced dose-related gastric ecl cell hyperplasia and ecl cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion.

i to undersøgelser over carcinogenicitet hos rotter frembragte lansoprazol dosis- relateret gastrisk ecl cellehyperplasi og ecl cellecarcinoider forbundet med hypergastrinæmi grundet hæmning af syresekretionen og retinal atrofi.
in two rat carcinogenicity studies, lansoprazole produced dose-related gastric ecl cell hyperplasia and ecl cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion and retinal atrophy.

i to carcinogenicitetsforsøg med rotter fremkaldte lansoprazol dosisrelateret gastrisk ecl - cellehyperplasi og ecl- cellecarcinoider, der blev forbundet med hypergastrinæmi på grund af hæmningen af syresekretion.
in two rat carcinogenicity studies, lansoprazole produced dose-related gastric ecl cell hyperplasia and ecl cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion.

c-cellehyperplasi og adenomer sås hos rotter og mus uanset dosisniveau og nul-bivirknings-niveauet (noael) kunne ikke defineres.
c-cell hyperplasia and adenoma were seen at all doses in rats and a no observed adverse effect level (noael) could be not defined.

Ændringer inkluderede øget alaninaminotransferase og alkalifosfataseaktivitet og histopatologiske fund (hovedsageligt sinusoidecelle- eller kupffer-cellehyperplasi/hypertrofi, galdegangshyperplasi og periportal fibrose).
alterations included increased alanine aminotransferase and alkaline phosphatase activity and histopathology findings (mainly sinusoidal cell or kupffer cell hyperplasia/hypertrophy, bile duct hyperplasia and periportal fibrosis).